[Radiation treatment in advanced cancer of the lung].
This is an attempt to evaluate the results of the radiotherapeutic treatment in patients with advanced lung cancer. The results of a series of 200 patients with lung cancer no oat cell. Average age: 59 years, ranging from 39 to 78, with male frank predominance (174/200). The histologic diagnosis was obtained in 159/200 (79.5%) of the patients of which, 52.8% were epidermoid carcinomas. The series was classified in three staging according to the American Joint Committee for Cancer Staging and End Results Reporting (AJC); the results was: 172/100 (86%) E III and 28/200 (14%) E I and II. The main objective of this work was the anlysis of E III which was subdivided into E III M0 and E III M1 for its study according to the absence or presence of metastasis when making the diagnosis. Besides, the patients were classified according to their clinical state at the beginning of treatment (performance status) following the Zubrod's scales. The statistics analysis shows the prognostic relevance of this parameter. The results of the two plans of irradiation treatment were analysed: continuous cycle (60 Gy in 6 weeks) and split course (2 cycles of 30 Gy in two weeks with three weeks of rest in between). There were not statisticaly significant difference either in the clinical or in the radiological response in both groups. Both groups were correlated under the following parameters: a) Performance Status, b) immediate response to treatment, c) quality of life after radiotherapy.(ABSTRACT TRUNCATED AT 250 WORDS)
Zunino
S
S
Kuschnir
E
E
Pérez
A
A
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D011829:Radiation Dosage
Tratamiento radiante en cáncer avanzado de pulmón.